Ex vivo SARS-CoV-2 infection of human lung reveals heterogeneous host defense and therapeutic responses

Matthew Schaller(Pulmonary and Critical Care Associates), Borna Mehrad(University of Florida)
JCI Insight
August 6, 2021
Cited by 53


Related Papers